Airway diseases
PG17 Postgraduate course
Asthma phenotyping
Basic science
Therapeutic implications
Registration for this session is additional to the congress registration fee and is €171 on site, €153 standard.
Aims : Access educational materials here to present the innovations in asthma stratification that facilitate personalised therapeutic strategies; to highlight the importance of stratifying asthma patients for selecting the correct therapeutic approaches; to explain the importance of both clinical and biomarker assessment in patient stratification; and to indicate the value of molecular stratification for understanding disease-driving mechanisms and how this may translate to new therapies, particularly for non-Type 2 (T2) asthma.
Target audience :
Allergist, General practitioner, Lung function technologist, Pathologist, Scientist (basic, translational), Student, Trainee, Adult pulmonologist/Clinician
Methods :
Cell and molecular biology, Physiology
14:00
The need for asthma phenotyping
S. Saglani(London, United Kingdom)
COI
189
14:30
Biomarker-high patients and steroid responsiveness
P. Gibson(Newcastle, Australia)
COI
190
15:00
Group assignment
S. Saglani(London, United Kingdom)
COI
P. Gibson(Newcastle, Australia)
COI
191
16:00
Unbiased approaches to asthma stratification - the road to novel therapies
P. Sterk(Koudekerk aan den Rijn, Netherlands)
COI
193
16:30
Patient stratification and targeted drug therapy - T2 asthma and beyond
P. Nair(Hamilton (ON), Canada)
COI
194
17:00
Group assignment
P. Sterk(Koudekerk aan den Rijn, Netherlands)
COI
P. Nair(Hamilton (ON), Canada)
COI
195
. . .